Conjugate Vaccine Market

Conjugate Vaccine Market by Disease Indication (Pneumococcal, Influenza, Diphtheria Tetanus Pertussis, Meningococcal), Type (Monovalent, Multivalent), Patient Stage (Pediatrics, Adults), Pathogen Type (Bacterial, Viral, Combination) - Forecasts to 2019

Report Code: UC 1375 Dec, 2018, by marketsandmarkets.com

The conjugate vaccines market is expected to reach $13.5 billion by 2019 from $7.5 billion in 2014, at a CAGR of 12.5%. Major factors driving growth of this market include increasing use of conjugate vaccines for adults, rising number of regulatory approvals for conjugate vaccines, rising prevalence of diseases, and technological advancements. However, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine are expected to restrain the growth of this market. Emerging economies such as India and China present an array of opportunities for this market.

North America dominates the conjugate vaccines market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period owing to the governmental initiatives, rising focus of major players on the Indian market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.

Prominent players in the conjugate vaccines market are Bharat Biotech (India), Biological E (India), CSL Limited (Australia), GlaxoSmithKline, plc. (U.K.), Merck and Company (U.S.), Neuron Biotech (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India.

Scope of the Report

This research report covers the vaccines market by type, disease indication, pathogen type, end user, and geography.

Vaccines Market, by Type

  • Monovalent Conjugate Vaccines
  • Multivalent Conjugate Vaccines

Vaccines Market, by Disease Indication

  • Pneumococcal
  • Influenza
  • DTP
  • Meningococcal
  • Others

Vaccines Market, by Pathogen Type

  • Bacterial Conjugate Vaccine
  • Viral Conjugate Vaccine
  • Combination (Viral and Bacterial) Conjugate Vaccine

Vaccines Market, by Patient Stage

  • Pediatrics Conjugate Vaccine
  • Adults Conjugate Vaccine

Vaccines Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia
  • Rest of the World (RoW)

Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1375
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Conjugate Vaccine Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved